Louise Longworth
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
What do HTA agencies need for generating health-related quality of life evidence? Findings from a global survey.
Journal: International journal of technology assessment in health care
Published: February 26, 2026
A United Kingdom Value Set for the EQ-5D-5L.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: October 15, 2025
The Economic Burden of Anti-Vascular Endothelial Growth Factor on Patients and Caregivers in the UK, Europe, and North America.
Journal: Ophthalmology and therapy
Published: March 24, 2025
Economic burden and quality of life of caregivers of patients with sickle cell disease in the United Kingdom and France: a cross-sectional study.
Journal: Journal of patient-reported outcomes
Published: May 02, 2024
A scoping review of the use of minimally important difference of EQ-5D utility index and EQ-VAS scores in health technology assessment.
Journal: Health and quality of life outcomes
Published: April 24, 2024
Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma.
Journal: The patient
Published: March 11, 2024
Correction to: A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published Literature.
Journal: The patient
Published: February 28, 2024
Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer.
Journal: Health and quality of life outcomes
Published: November 23, 2023
A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published Literature.
Journal: The patient
Published: November 19, 2023
A time trade-off study to determine health-state utilities of transplant recipients with refractory cytomegalovirus infection with or without resistance.
Journal: Health and quality of life outcomes
Published: August 25, 2023
An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective.
Journal: Eye (London, England)
Published: July 13, 2023
Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection.
Journal: Health and quality of life outcomes
Published: June 20, 2023
Last Updated: 09/26/2026